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Granulosa cell proliferation is inhibited by PGE2 in the primate ovulatory follicle
Patric S. Lundberga, Gil J. Moskowitzb, Carmel Bellacosec, Esra Demirelc, Heidi A. Trauc and Diane M. Duffyc
aDepartment of Microbiology and Medical Molecular Biology, Eastern Virginia Medical School, Norfolk, VA, USA; bDepartment of Department of
Computer Science, Old Dominion University, Norfolk, VA, USA; cDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk,
VA, USA
ABSTRACT
Prostaglandin E2 (PGE2) is a key paracrine mediator of ovulation. Few specific PGE2-regulated gene
products have been identified, so we hypothesized that PGE2 may regulate the expression and/or
activity of a network of proteins to promote ovulation. To test this concept, Ingenuity Pathway
Analysis (IPA) was used to predict PGE2-regulated functionalities in the primate ovulatory follicle.
Cynomolgus macaques underwent ovarian stimulation. Follicular granulosa cells were obtained
before (0 h) or 36 h after an ovulatory dose of human chorionic gonadotropin (hCG), with
ovulation anticipated 37–40 h after hCG. Granulosa cells were obtained from additional monkeys
36 h after treatment with hCG and the PTGS2 inhibitor celecoxib, which significantly reduced
hCG-stimulated follicular prostaglandin synthesis. Granulosa cell RNA expression was determined
by microarray and analyzed using IPA. No granulosa cell mRNAs were identified as being
significantly up-regulated or down-regulated by hCG + celecoxib compared with hCG only.
However, IPA predicted that prostaglandin depletion significantly regulated several functional
pathways. Cell cycle/cell proliferation was selected for further study because decreased
granulosa cell proliferation is known to be necessary for ovulation and formation of a fully-
functional corpus luteum. Prospective in vivo and in vitro experiments confirmed the prediction
that hCG-stimulated cessation of granulosa cell proliferation is mediated via PGE2. Our studies
indicate that PGE2 provides critical regulation of granulosa cell proliferation through
mechanisms that do not involve significant regulation of mRNA levels of key cell cycle
regulators. Pathway analysis correctly predicted that PGE2 serves as a paracrine mediator of this
important transition in ovarian structure and function.
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Introduction
The midcycle surge of luteinizing hormone (LH) initiates
structural and functional changes within the ovulatory
follicle which culminate in release of the oocyte and for-
mation of the corpus luteum (Duffy et al. 2019). Follicular
prostaglandins are low prior to the LH surge. The LH
surge initiates follicular synthesis of prostaglandins and,
in particular, prostaglandin E2 (PGE2) (Sirois 1994; Sirois
and Dore 1997; Mikuni et al. 1998; Duffy and Stouffer
2001). Locally-elevated PGE2 is a critical mediator of ovu-
latory changes including expansion of cumulus granu-
losa cells, angiogenesis, follicle rupture, and release of
an oocyte capable of fertilization (Duffy 2015; Trau
et al. 2015). Blockade of PGE2 synthesis or action
results in unruptured follicles with retained oocytes
(Hizaki et al. 1999; Tilley et al. 1999; Duffy and Stouffer
2002).
PGE2 plays a critical role in ovulation. Perhaps surpris-
ingly, few PGE2-regulated gene products have been
identified in the ovulatory follicle. Gene array analyses
focusing on gene expression regulated by the LH surge
(or hCG in experimental models) have identified numer-
ous gonadotropin-regulated genes in ovarian cells and
tissues from rodents, domestic animals, monkeys, and
humans (Fan et al. 2009; Xu et al. 2011; Christenson
et al. 2013; Wissing et al. 2014). Since the LH surge
initiates synthesis of ovulatory prostaglandins, we
might expect that prostaglandin-regulated genes
should be a subset of all LH-regulated genes. A few pros-
taglandin-regulated genes have been identified in pro-
spective studies of LH-regulated genes (Seachord et al.
2005; Li Q et al. 2006; Sayasith et al. 2008; Markosyan
and Duffy 2009). Additional prostaglandin-regulated
gene products have been identified after ovulatory dys-
functions were noted in mice lacking expression of the
key prostaglandin synthesis enzyme PTGS2 (Hizaki
et al. 1999; Tilley et al. 1999). However, the well-estab-
lished failure of ovulation in the absence of
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36 h hCG and 0 h hCG (Figure 1(A)). IPA was also used to
identify networks showing changes between treatment
with 36 h hCG + celecoxib treatment and 36 h hCG
only (Figure 1(B)). For each comparison, the total list of
differentially-regulated genes (Table 2) as well as IPA pre-
dicted upstream regulators (Table 3) were connected to
generate the networks. In addition, colors indicating the
direction of change in mRNA expression were overlaid
for each panel in Figure 1. IPA’s Molecule Activation Pre-
dictor function colorizes network connections as blue or
orange when gene expression changes are consistent
with known gene relationships, and yellow when the
relationship is inconsistent. In both panels, numerous
blue and orange connections highlight the importance
of cell cycle regulation and pro-inflammatory responses
within these networks.
Granulosa cell proliferation is controlled by
gonadotropin and prostaglandins
Many of the upstream regulators predicted by pathway
analysis of our array data (Table 3) are associated with
cell cycle regulation. Importantly, three of these pre-
dicted upstream regulators (e.g. E2F2, RBL1, CCND1)
Figure 1. Predicted granulosa cell gene networks regulated by hCG and celecoxib. Top up-regulated genes and down-regulated genes
(TG) and IPA-predicted change in upstream regulator (UR) gene activity when comparing 36 h hCG versus 0 h hCG (Panel A) and 36 h
hCG + celecoxib versus 36 h hCG (Panel B). Transcripts were included where TG with a change above absolute 2 (Table 1) and predicted
UR with an estimated significance below p=0.05/Z-score > ABS(2.1) (Table 2). For clarity, p53 and Rb (purple) were not included in the
network build as they connected with most nodes in Panel A. Shown is the subcellular view option in IPA, with nuclear localization is at
the bottom and extracellular/secreted proteins are at the top; cytoplasmic and plasma membrane proteins are located as indicated.
Transcript icons and color scheme are IPA defaults. Briefly, red, orange and yellow are up-regulated, blue and green are down-regu-
lated, and gray are unknown/no prediction as either actual or predicted depending on molecule. Overlays and predictions (provided by
the Molecule Activity Predictor function in IPA) were done using transcript expression values for the respective comparison analysis.
Table 3. Upstream regulators predicted to be significantly regulated with hCG treatment (36 h hCG/0 h hCG) or with celecoxib
treatment (36 h hCG+celecoxib/36 h hCG) based on experimental data.
Molecule Type
36 h hCG/0 h hCG 36 h hCG+celecoxib/36 h hCG
Activated Inhibited Activated Inhibited
Growth Factor TGFB1, AGT IL5 TGFB2, INHBA
Kinases ATM MAP2K1, MAP3K1
Transcription Regulators CDKN2A, NUPR1, SMARCB1, HSF1, RB1,
PPRC1, CEBPB, TP53, EZH2, RBL1, ERG
CCND1, MYCN, MYC, FOXM1,
NCOA3, E2F2, E2F1
E2F2, CCND1,E2F4 SMAD3, SMARCA4, ERG, RBL1,
KDM5A, RUVBL1
MicroRNA let-7 miR-17-5p let-7
Enzymes NDUFA13
Cytokines TNF, CSF2, WNT5A, OSM, IL1A, IL1B IL21 WNT5A
Other PGR, SHH, A2M S100A6, SFTPA1, PCM1 S100A6, EIF4G1 CD24, IGF1R, IGFBP2
Italics indicates regulators which differ in both groups, but note that the direction of regulator activity change differs in all cases, meaning that celecoxib counters
the directional regulation by hCG.
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are implicated in control of cell cycle progression
(Johnson and Walker 1999). Therefore, cell cycle regu-
lation was selected for further analysis.
A network of E2F2-regulated genes was overlaid with
ratios of mRNA expression data from 36 h hCG/0 h hCG
and 36 h hCG + celecoxib/36 h hCG (Figure 2). These
comparisons were selected because they are physiologi-
cally meaningful. The ratio of 36 h hCG/0 h hCG reflects
changes stimulated by hCG as the follicle transitions
from a dominant preovulatory follicle to a luteinizing fol-
licle just before ovulation (Figure 2(A)). Treatment with
hCG decreases expression of many cell cycle regulators,
as denoted by the green color. Importantly, the majority
of these proteins increase the rate of cell proliferation. In
addition, hCG increased expression of CDKN1A, an
inhibitor of cell cycle progression. It is important to
note that the overall impact of hCG is to subtly, but
not significantly, alter the mRNA expression of many
cell cycle regulators, with the net effect of decreasing
cell proliferation.
In contrast, the ratio of 36 h hCG + celecoxib/36 h hCG
shows the impact of prostaglandin depletion in the ovu-
latory follicle (Figure 2(B)). The overlay shows that prosta-
glandin depletion effectively reverses the effect of hCG,
upwardly shifting expression of many gene products
which increase cell proliferation and downwardly shift-
ing expression expression of a cell cycle inhibitor,
CDKN1A. These data demonstrate that the role of hCG-
stimulated prostaglandins is to subtly shift cell cycle to
decrease the rate of cell proliferation. However, no
single mRNA is significantly increased or decreased by
prostaglandins.
E2F2 is the predicted locus of control for this pathway
(Figure 2). IPA predicted that an ovulatory dose of hCG
decreases E2F2 activity as a control point for shifting
granulosa cells from a highly proliferative state to a
state of very limited cell cycle progression. Furthermore,
this analysis predicted that prostaglandins (stimulated by
hCG) subtly alter mRNA expression of this same cluster of
gene products to decrease cell cycle progression by via
the activity of E2F2.
Experiments confirmed that mRNA levels for two cell
cycle regulators, CCNB1 and CCNE1, decreased after
exposure to hCG in vivo (Figure 3(A,B)). Treatment with
36 h hCG + celecoxib did not alter CCNB1 and CCNE1
levels when compared to treatment with 36 h hCG only
(Figure 3(A,B)). These findings are consistent with gene
expression levels in Figure 2. In this Figure, inhibition of
cell cycle regulation was seen in the 36 h hCG/0 h hCG
ratio and activation of cell cycle regulation was seen in
the 36 h hCG + celecoxib/36 h hCG ratio, albeit subtle.
Additional prospective studies were conducted to test
the hypothesis that prostaglandins mediate hCG-regu-
lated reduction in cell cycle progression by follicular
granulosa cells. Ki67 immunodetection was performed
to determine the percentage of monkey granulosa cells
engaged in cell cycle progression before hCG treatment
(0 h hCG), at specific times after hCG administration, and
after treatment with 36 h hCG + celecoxib in vivo (Figure
3(C–F)). Before hCG administration, 45 ± 5% of granulosa
cells were Ki67 + . The percentage of Ki67+ granulosa
cells was significantly reduced 24 h after hCG adminis-
tration (31 ± 4%), and only 11 ± 3% of granulosa cells
were Ki67+ by 36 h after hCG administration. Co-admin-
istration of hCG and celecoxib yielded 39 ± 6% of granu-
losa cells determined to be Ki67+, similar to the
percentage of Ki67+ granulosa cells observed at 0 h
hCG. To determine if the specific prostaglandin PGE2 is
Figure 2. E2F2 is a predicted node for regulation of granulosa cell cycle modulators. Panel A. Comparison of 36 h hCG-treated vs
untreated granulosa cells (36 h / 0 h) showed IPA predicted down-regulation (green) as the primary effect of the predicted inhibition
(blue) of E2F2. Panel B. Comparison of 36 h hCG + celecoxib versus 36 h hCG in vivo (36 h + celecoxib/36 h) showed IPA predicted pre-
dominantly up-regulation (red) as the effect of the predicted activation (orange) of E2F2 in granulosa cells.
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Figure 3. hCG and PGE2 regulate granulosa cell proliferation. Panels A-B. CCNB1 (A) and CCNE1 (B) levels in monkey granulosa cells
obtained after ovarian stimulation without (0 h) hCG or 12, 24, or 36 h after administration of hCG; additional monkeys received
hCG and celecoxib for 36 h (36+C). mRNA of interest was expressed relative to ACTB. Panel C. The percentage of Ki67 immunopositive
granulosa cells in monkey ovarian tissues obtained after treatments described for Panels A-B. For each panel A-C, groups with no
common superscripts are different by ANOVA and Duncans post hoc test, p<0.05; n=3–5 monkeys/time or treatment. Panels D-F. Repre-
sentative images of Ki67 immunodetection in monkey granulosa cells (lower portion of each image) obtained after treatment with 0 h
hCG (D), 36 h hCG (E), and 36 h hCG + celecoxib (F). Example Ki67+ (arrow) and Ki67- (arrowhead) nuclei are indicated in Panel D; inset
in panel F shows lack of stain in granulosa cells when primary antibody was omitted. Panels G-H. Human granulosa cells received indo-
methacin alone (control) or in combination with hCG, PGE2, or hCG + PGE2 for 24 h (G) or 48 h (H) before Ki67 immunodetection; n = 4
women/treatment. For each panel G-H, groups with no common superscripts are different by ANOVA with one repeated measure (for
repeated use of each woman’s cells) and Duncans post hoc test, p < 0.05. Panels I-L. Representative images of Ki67 immunodetection in
human granulosa cells cultured for 48 h with control media (I), hCG (J), PGE2 (K), or hCG + PGE2 (L). Example Ki67+ (arrow) and Ki67-
(arrowhead) nuclei are indicated in panel I. Inset in panel J shows lack of stain in granulosa cells when primary antibody was omitted.
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PTGS2 product is necessary for hCG to reduce prolifer-
ation in granulosa cells. Our in vitro studies of human
granulosa cells identified PGE2 as the key prostaglandin
involved in cell cycle regulation. Previous reports find
limited evidence of a correlation between prostaglandins
and granulosa cell proliferation (Wang et al. 1992; Li J et al.
1996; Mori et al. 2011; Li F et al. 2012), but there was no
consensus as to whether prostaglandins promote or
inhibit cell cycle progression. Some studies demonstrate
that granulosa cell exit from cell cycle begins before pros-
taglandins accumulate in the follicle (Mikuni et al. 1998;
Duffy and Stouffer 2001), indicating that the ovulatory
gonadotropin surge is likely the initial stimulus for granu-
losa cell cycle exit. However, the present study shows that
a PTGS2 product is needed for cell cycle exit in vivo, and
PGE2 is able to stimulate primate granulosa cell exit from
cell cycle in vitro. While gonadotropin likely initiates cell
cycle exit in vivo, gonadotropin-stimulated production of
PGE2 is needed to achieve and maintain very low rates
of granulosa cell proliferation which occur at the time of
ovulation and luteal formation.
Cessation of proliferation is a prerequisite for differen-
tiation from the follicular granulosa cell phenotype to the
luteal cell phenotype (reviewed in (Robker and Richards
1998)). Functional luteinization, as defined by elevated
progesterone production, is initiated by gonadotropin,
independent of prostaglandins, in non-human primates
and women (Duffy 2015). Structural luteinization
includes granulosa cell hypertrophy to become large
luteal cells, formation of a capillary network within the
granulosa cells, and replacement of the antral space
with a mature corpus luteum; these changes do not
occur when prostaglandin synthesis is inhibited during
exposure to an ovulatory dose of gonadotropin (Kim
et al. 2014; Trau et al. 2015). A critical role for follicular
prostaglandins in granulosa cell cycle exit is consistent
with the formation of luteinized unruptured follicles. In
women with endogenous LH surges or receiving hCG
to initiate ovulatory events, co-administration of a pros-
taglandin synthesis inhibitor caused the formation of
luteinized unruptured follicles (Killick and Elstein 1987;
Pall et al. 2001; Jesam et al. 2010). These follicles continue
to increase in diameter after the LH surge or hCG and can
remain as fluid-filled, cystic structures for a week or more
after an ovulatory dose of gonadotropin. Similar studies
in non-human primates and cows used intrafollicular
administration of a prostaglandin synthesis inhibitor to
prevent elevated follicular prostaglandins after adminis-
tration of a ovulatory dose of hCG. These treatments
resulted in formation of enlarged, cystic structures with
multiple layers of unluteinized, proliferative granulosa
cells (Peters et al. 2004; Kim et al. 2014). Normal or
near-normal serum progesterone levels measured in
these studies support the concept that functional luteini-
zation occurs in the absence of prostaglandins. Elevated
intrafollicular prostaglandins are involved in structural
luteinization and contribute to this process, at least in
part, by stimulating granulosa cell exit from cell cycle.
The study presented here used non-human primate
granulosa cell RNA obtained after specific conditions of
hCG administration and prostaglandin depletion to facili-
tate identification of a previously-unappreciated network
of prostaglandin-sensitive granulosa cell gene products.
However, this approach did not identify many granulosa
cell mRNAs previously shown to be hCG-regulated in
human and non-human primate ovarian cells (Xu et al.
2011; Wissing et al. 2014; Yerushalmi et al. 2014).
Oocytes and surrounding cumulus were manually
removed from our follicular aspirates, so the cells used
for gene array analysis in the present study were
thought to be primarily (but not exclusively) mural gran-
ulosa cells. Prostaglandin-regulated gene products impli-
cated in cumulus expansion in rodents (reviewed in
(Russell and Robker 2007)) were likely not identified in
the present study since many cumulus cells were
removed prior to preparation of cDNA for analysis.
Expression levels for many mural granulosa cell gene
products increase immediately after the LH surge or
hCG administration and are low again by the time of ovu-
lation in primates (Chaffin et al. 1999, 2000; Duffy, Dozier,
et al. 2005). mRNAs regulated in this fashion would not
be detected by our analysis. Focused analysis of chan-
ging patterns of gene expression late in the ovulatory
interval allowed identification of cell cycle regulation as
a PGE2-sensitive process that is essential for both ovu-
lation and formation of a fully-functional corpus luteum.
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